Hepatic Disease in Patients With HIV
Summary
- Studies of hydroxymethylglutaryl-CoA reductase inhibitors (statins) have reported some evidence of reductions in serum ALT[Gómez-Domínguez 2006; Hatzitolios 2004; Athyros 2006; Abel 2009]
- The US National Lipid Association Statin Liver Safety Task Force has concluded that statin therapy is safe in patients with NAFLD and dyslipidemia[Bays 2014]
- The AASLD and EASL guidelines recommend the use of statins for treatment of dyslipidemia in patients with NAFLD and NASH[AASLD NAFLD; EASL NAFLD]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content